HIV, the virus that causes AIDS, has killed close to 30 million people since the epidemic emerged in the early 1980s. Scientific American editor Christine Gorman explains why HIV is so difficult for the body to fight and for doctors to treat...
Also called cell-transfer therapy, it is one of a new class of approaches being developed to strengthen the innate ability of the immune system to fight cancer
Instead of making immune-compromised cancer patients suffer long and potentially dangerous waits in the emergency room, Richard Dean, PhD, envisioned and championed a better solution.
An unusual enzyme called telomerase acts on parts of chromosomes known as telomeres. The enzyme has recently been found in many human tumors and is being eyed as a new target for cancer therapy...
Advancing cancer care requires more than just science. It’s a collective effort driven by passionate individuals and organizations quietly working to make a difference for those living with and affected by cancer...
While many community oncology clinics struggle to use the most advanced tools, Lincoln D. Nadauld, MD, makes advanced genomic testing the standard of care — with astonishing results...